SUPPLEMENTARY INFORMATION INFORMATION 5 FIGURE S5 a SMAD4 JP Polyp Lkb1 PJ Polyp Yap1 ABL2 MID1 FST...

8
SUPPLEMENTARY INFORMATION WWW.NATURE.COM/NATURECELLBIOLOGY 1 DOI: 10.1038/ncb2884 a YAP siTAOK1 siMAP2K7 siMAP3K9 siMAP4K4 siMAPKAPK5 siMAP4K5 siABL2 siLY6G5B siNEK4 siSTK10 siAKAP8 siTRAFIP3 siCTR siNF2 siAKAP8 siLY6G5B siMAP2K7 siMAP3K9 siMAP4K4 siMAP4K5 siCTR siNF2 siMAPKAPK5 siTRAF3IP3 siSTK10 siTAOK1 pYap Yap GAPDH b 60 60 30 -2 0 2 4 6 8 CTR NF2 MAP2K1 MAP2K1IP1 MAP2K2 MAP2K5 MAP3K1 MAP3K2 MAP3K3 MAP4K3 MAPK1 MAPK12 MAPK15 MAPK3 MAPK4 MAPK6 MAPK7 MAPKAPK3 MAP2K7 MAP3K10 MAP3K11 MAP3K12 MAP3K13 MAP3K14 MAP3K4 MAP3K5 MAP3K6 MAP3K7 MAP3K7IP2 MAP3K8 MAP3K9 MAP4K1 MAP4K2 MAP4K4 MAP4K5 MAPK10 MAPK8 MAPK9 MAP2K3 MAP2K4 MAP2K6 MAP3K15 MAPK11 MAPK13 MAPK14 MAPKAPK2 MAPKAPK5 Relative Fold Change ERK SIGNALING JNK SIGNALING p38 SIGNALING c UPSTREAM SIGNALING MAP3K MEK4/7 JNK2 DOWNSTREAM TARGETS JNKII (40 nM) JNKIX PD98059 JNK1 JNK3 JNKIX JNKII (90 nM) JNKII (40 nM) d 0 5 10 15 20 25 30 Relative Fold Change Untreated DMSO JNK II (40) JNK II (90) JNKIX PD98059 Supplementary Figure 1 Identification of kinases that can modulate the Hippo Signaling Pathway in vitro. (a) Immunofluorescence for YAP localization in confluent HaCaT cells following siRNA transfection of selected kinase hits. Scale bars, 200mm. Experiment was repeated 3 times independently (b) Western Blot for YAP S127 phosphorylation, and total YAP in 293T cells four days following siRNA transfection of selected kinase hits. Representative blot is shown. This experiment was repeated 3 independent times (c) Mitogen activated kinase pathway siRNA mini-screen using the STBS-luciferase reporter in 293T cells compared to scrambled control (CTR). Data shown is from technical triplicates. The experiment was repeated in three independent experiments. 5 bD) Selective JNK small molecule screen using the STBS-luciferase reporter in 293T cells. Schematic demonstrates where the inhibitors function. Fold changes calculated are compared to untreated controls. © 2014 Macmillan Publishers Limited. All rights reserved.

Transcript of SUPPLEMENTARY INFORMATION INFORMATION 5 FIGURE S5 a SMAD4 JP Polyp Lkb1 PJ Polyp Yap1 ABL2 MID1 FST...

Page 1: SUPPLEMENTARY INFORMATION INFORMATION  5 FIGURE S5 a SMAD4 JP Polyp Lkb1 PJ Polyp Yap1 ABL2 MID1 FST SLC16A6 ACAT2 MIR622 GADD45A SLC2A3 ACLY MYBL1 GADD45B

S U P P L E M E N TA RY I N F O R M AT I O N

WWW.NATURE.COM/NATURECELLBIOLOGY 1

DOI: 10.1038/ncb2884

FIGURE S1

aYAP

siTAOK1 siMAP2K7

siMAP3K9 siMAP4K4

siMAPKAPK5 siMAP4K5siABL2

siLY6G5B siNEK4

siSTK10

siAKAP8 siTRAFIP3

siCTR

siNF2

siAKAP8

siLY6G

5B

siMAP2K

7

siMAP3K

9

siMAP4K

4

siMAP4K

5

siCTR

siNF2

siMAPKAPK5

siTRAF3IP

3

siSTK10

siTAOK1

pYap

Yap

GAPDH

b

60

60

30

-2

0

2

4

6

8

CTR NF2

MAP

2K1

MAP

2K1I

P1M

AP2K

2M

AP2K

5M

AP3K

1M

AP3K

2M

AP3K

3M

AP4K

3M

APK1

MAP

K12

MAP

K15

MAP

K3M

APK4

MAP

K6M

APK7

MAP

KAPK

3M

AP2K

7M

AP3K

10M

AP3K

11M

AP3K

12M

AP3K

13M

AP3K

14M

AP3K

4M

AP3K

5M

AP3K

6M

AP3K

7M

AP3K

7IP2

MAP

3K8

MAP

3K9

MAP

4K1

MAP

4K2

MAP

4K4

MAP

4K5

MAP

K10

MAP

K8M

APK9

MAP

2K3

MAP

2K4

MAP

2K6

MAP

3K15

MAP

K11

MAP

K13

MAP

K14

MAP

KAPK

2M

APKA

PK5

Rel

ativ

e Fo

ld C

hang

e

ERK SIGNALING JNK SIGNALING p38 SIGNALINGc

UPSTREAM SIGNALING

MAP3K

MEK4/7

JNK2

DOWNSTREAM TARGETS

JNKII (40 nM) JNKIX

PD98059

JNK1 JNK3JNKIX

JNKII (90 nM)JNKII (40 nM)

d

0

5

10

15

20

25

30

Rel

ativ

e Fo

ld C

hang

e

UntreatedDMSO

JNK II (40)

JNK II (90)

JNKIXPD98059

Supplementary Figure 1 Identification of kinases that can modulate the Hippo Signaling Pathway in vitro. (a) Immunofluorescence for YAP localization in confluent HaCaT cells following siRNA transfection of selected kinase hits. Scale bars, 200mm. Experiment was repeated 3 times independently (b) Western Blot for YAP S127 phosphorylation, and total YAP in 293T cells four days following siRNA transfection of selected kinase hits. Representative blot is shown. This experiment was repeated 3

independent times (c) Mitogen activated kinase pathway siRNA mini-screen using the STBS-luciferase reporter in 293T cells compared to scrambled control (CTR). Data shown is from technical triplicates. The experiment was repeated in three independent experiments. 5 bD) Selective JNK small molecule screen using the STBS-luciferase reporter in 293T cells. Schematic demonstrates where the inhibitors function. Fold changes calculated are compared to untreated controls.

© 2014 Macmillan Publishers Limited. All rights reserved.

Page 2: SUPPLEMENTARY INFORMATION INFORMATION  5 FIGURE S5 a SMAD4 JP Polyp Lkb1 PJ Polyp Yap1 ABL2 MID1 FST SLC16A6 ACAT2 MIR622 GADD45A SLC2A3 ACLY MYBL1 GADD45B

S U P P L E M E N TA RY I N F O R M AT I O N

2 WWW.NATURE.COM/NATURECELLBIOLOGY

pYap

Yap

GAPDH

HaCaT MCF-7 DLD1

siCTR

siCTR

siCTR

siNF2

siNF2

siNF2

siLKB1

siLKB1

siLKB1

0

5

10

siCTR

siLKB1siNF2

Rel

ativ

e Fo

ld C

hang

e

a

0

20

40

60

80

Scrambled +siLKB1 - Am 1 3 5 6

Dharmacon

Rel

ativ

e Lu

cife

ase

Uni

t

DLD1 MCF7 HaCaT 293T

Supplementary Figure 2

Rel

ativ

e Ex

pres

sion

1

LKB1 YAP

0.5

1.5

0.0

siLKB1

siLKB1/siYap

siYap

siCTR

0

0.2

0.4

0.6

0.8

1

1.2

Rel

ativ

e Lu

cife

rase

Uni

t **

- +dox 0

0.20.40.60.81

1.21.41.6

Rat

io C

-MST

1/M

ST1

**

LKB1+/+ -/-

0

20

40

60

80

100

120CytoNuclear

CTR siMST siLats- dox - dox - dox+ dox + dox + dox

F-actin YAP OVERLAY

+dox

siC

TRsi

MST

1/2B

siM

ST1/

2Csi

Lats

2Asi

Lats

2B

% P

ositi

ve C

ells

GFP-LKB1 + +Flag-LATS1 - +

Inpu

t

GFP

FLAG

GFP

FLAG

IP:α

-FLA

G GFP-LKB1

GFP

FLAG

FLAG

GFP

Flag-MST1Flag-Empty

--+

++ +

Inpu

tIP

:α-F

LAG

b c

e f g

kh i j

60

60

80

30

260

160

260

160

110

80

110

80

110

80

110

8060

50

60

50

siCTR

siLKB1DLD

1

YAPsiCTR

siLKB1

d

Supplementary Figure 2 LKB1 acts upstream of the Hippo Signaling Pathway in vitro and in vivo. (a) Knockdown of LKB1 using multiple different siRNA oligos increases STBS-luciferase reporter activity in 293T cells. n= 5 biological replicates ± SD. (b) Knockdown of LKB1 reproducibly increases STBS-luciferase reporter activity across various cell lines. n=3 biological replicates. Error bars represent mean ± SD. (c) Knockdown of LKB1 reproducibly decreases YAP S127 phosphorylation across various cell lines by western blot analysis. (d) Knockdown of LKB1 in DLD1 cells promotes YAP nuclear localization at confluent cell densities. Experiment has been performed independently three times. Scale bar, 200mm (e) qPCR validation of LKB1 and YAP siRNA knockdown in 293T cells. n=3 biological replicates, ± SD. (f) LKB1 activation in W4 cells repressed TEAD-reporter activation.

n= 3 replicates per biological triplicate (g) Decreased activity of MST1/2 in LKB1 deficient livers. Ratio of cleaved MST1 versus full length MST is shown for an average from n=4 mice. (h) Quantification of YAP localization in W4 cells following MST1/2 or LATS1/2 knockdown. Data are derived from three independent experiments where at least 300 cells where scored. N = 3, error bars represent mean ± SD. (i) Validation of MST1/2 and LATS2 downstream of LKB1 using two additional sets of siRNAS. Representative figure from three independent experiments is shown. Scale bars, 20mm (j, k) Immunoprecipitation of overexpressed LKB1, LATS1, and MST1 in 293T cells. Representative blot is shown. Experiment has been performed three times independently. Error bars represent mean ± SD from triplicate samples. **, P≤ 0.01, two-tailed t-test.

© 2014 Macmillan Publishers Limited. All rights reserved.

Page 3: SUPPLEMENTARY INFORMATION INFORMATION  5 FIGURE S5 a SMAD4 JP Polyp Lkb1 PJ Polyp Yap1 ABL2 MID1 FST SLC16A6 ACAT2 MIR622 GADD45A SLC2A3 ACLY MYBL1 GADD45B

S U P P L E M E N TA RY I N F O R M AT I O N

WWW.NATURE.COM/NATURECELLBIOLOGY 3

a

FIGURE S3

0.0

1.0

2.0

3.0

4.0

5.0

6.0

7.0

8.0

9.0

10.0

MARK1 MARK4 CTGF CYR61

siCTRsiMARK1-AsiMARK1-BsiMARK1-CsiMARK4-AsiMARK4-BsiMARK4-CR

elat

ive

Expr

essi

on

siC

TRsi

MA

RK

4-B

siM

AR

K4-

C

F-ACTIN YAP OVERLAY

+DO

X

b

CTR

siM

ARK

YAP

- DO

X

dOVERLAY

c

0

1

2

3

4

5

6

7

8

9

CTR siMARK4 siMARK4

Rel

ativ

e lu

cife

rase

uni

t

e

+siYao

Lats1/2

MOB

GAPDH

MARK4

siMARK4MLL OE

--

-+

+-

++

g

f

dox- +

pMARK

MARK1

GAPDH

260

160

110

80

30

30

20

30

110

80

110

80

80

60

80

60

20

10

50

4030

Supplementary Figure 3 Yap1 activity and localization is dependent on the LKB1 substrate, MARKs. (a) qPCR validation of siRNA knockdown of MARK1 and MARK4 and expression of YAP-target genes, CTGF and CYR61. n=3 biological replicates (b) STBS reporter activity following knockdown of MARK4 and YAP in 293T cells. n=3 biological replicates (c) Western blot showing expression level of Mob1/LATS1/LATS2 in MARK4 knockdown cells. Representative blot is shown from three independent experiments (d) Activation of LKB1 in W4 cells promotes activation of MARKs as measured by Thr215 phosphorylation (MARK1) in the kinase activation loop. Representative blot is shown from three independent

experiments (e) Immunofluorescence for YAP localization (green) and cell polarization (red) in doxycycline-untreated W4 cells following knockdown of MARK4. N= 3 biological replicates. Each experiment was performed with technical triplicates. Scale bar, 20mm. (f) YAP localization in W4 cells following LKB1 activation and knockdown of MARK4 using 2 independent siRNA’s. Three independent experiments were performed. Scale bars, 20mm. (g) Biochemical analysis of phospho-YAP localization by subcellular fractionation of W4 cells treated with doxycycline and MARK knockdown. Representative blot from three independent experiments is shown. Error bars represent mean ± SD.

© 2014 Macmillan Publishers Limited. All rights reserved.

Page 4: SUPPLEMENTARY INFORMATION INFORMATION  5 FIGURE S5 a SMAD4 JP Polyp Lkb1 PJ Polyp Yap1 ABL2 MID1 FST SLC16A6 ACAT2 MIR622 GADD45A SLC2A3 ACLY MYBL1 GADD45B

S U P P L E M E N TA RY I N F O R M AT I O N

4 WWW.NATURE.COM/NATURECELLBIOLOGY

00.20.40.60.8

11.21.4

LKB1 MARK1 SCRIB

siCTRsiLKB1siMARK1

siCTR

siMARK1

Rel

ativ

e ex

pres

sion

FIGURE S4

SCR

IBZ-

stac

k

DLD1CTR siLKB1 siMARK

a

012345678

siCTR siScrib

Rel

ativ

e lu

cife

rase

uni

t

0

20

40

60

80

100

120 CytoNuclear

CTR- dox + dox

siScrib- dox + dox

e fOVERLAYYAP

siC

TRsi

Scrib

- DO

X

gPr

e-IP LKB1

Lats

MST

IP: F

LAG

-MAR

K

LKB1

Mst1

Lats

FLAG

EV MARK4FLAG

Scrib

Scrib

i

% P

ositi

ve C

ells

00.20.40.60.8

11.2

siCTR

siScri

b-A

siScri

b-B

siScri

b-C

SCRIB

Rel

ativ

e Ex

pres

sion

hF-ACTIN YAP OVERLAY

siC

TRsi

SCR

IBA

siSC

RIB

C

siCTR

siLKB1

siMARK1

Scribble

LKB1

MARK1

GAPDH

c d

b

4030

110

80

110

260

80

siLKB1

260

80

80110

80

110260

60

60

50

11016050

110160

j

norm

aliz

edIP

: GFP

-MST

1

GFP

MARK1

Scrib

Pre-

IP LKB1

Scrib

siCTR

siMARK1

siLkb

1

260

80

260

80

110

80

110

110

____

____

____

Supplementary Figure 4 Scribble expression and correct localization is required for Yap1 activity. (a) Immunofluorescence for Scribble (SCRIB) localization (green) in DLD1 cells following LKB1 and MARK siRNA knockdown. Experiment was repeated three times. Scale bar, 200mm. (b-c) Immunoblot and qPCR for SCRIB expression following LKB1 and MARK1 knockdown in MCF7 cells. n=3 biological triplicates (d) siRNA knockdown of SCRIB in 293T cells induces TEAD-reporter activity. n = 3 independent experiments. (e) qPCR validation of SCRIB knockdown using 3 independent siRNA’s. n= 3 independent experiments. (f) Immunofluorescence for YAP localization (green) and cell polarization (red) in doxycycline-untreated W4

cells following knockdown of SCRIB. Biological replicates were performed three times. Scale bar, 20mm. (g) Quantification of YAP localization in W4 cells following scribble knockdown. Data are derived from three independent experiments where at least 300 cells where scored. (h) Immunofluorescence for YAP localization following activation of LKB1 and knockdown of scribble using 2 independent siRNA’s. Scale bar 20mm. (i) Immunoprecipitation of overexpressed MARK4 with SCRIB, LKB1, MST1, and LATS1. Experiment was repeated three times. (j) Immunoprecipitated SCRIB in MARK1-knockdown cells show decreased interaction with MST and LATS. Experiment was repeated three times. Error bars represent mean ± SD.

© 2014 Macmillan Publishers Limited. All rights reserved.

Page 5: SUPPLEMENTARY INFORMATION INFORMATION  5 FIGURE S5 a SMAD4 JP Polyp Lkb1 PJ Polyp Yap1 ABL2 MID1 FST SLC16A6 ACAT2 MIR622 GADD45A SLC2A3 ACLY MYBL1 GADD45B

S U P P L E M E N TA RY I N F O R M AT I O N

WWW.NATURE.COM/NATURECELLBIOLOGY 5

FIGURE S5

a SMAD4 JP Polyp Lkb1 PJ PolypYap1ABL2 MID1 FST SLC16A6

ACAT2 MIR622 GADD45A SLC2A3ACLY MYBL1 GADD45BACSL1 MYOF GCNT4 SLC43A3ACSL4 NCF2 GDPD3 SLC48A1ACSS2 NFKBIA GGT5 SLC5A1ADAMTS12 NID2 GPCPD1 SLC5A3AMOTL2 NPPB GPRC5A SLC7A7ANKRD1 NT5DC3 GPRC5B SLCO2A1ANXA3 NT5E HBEGF SLIT2AREG NUAK2 HMGCS1 SNAPC1AXL OLFML3 HSPB8 SNORA75BCAS1 OLR1 HSPC159 SNORD13P2C6ORF155 OPN3 ICAM1 SNORD21CALB2 P2RY8 IDI1 SNORD38ACCL28 PCYT2 IFFO2 SNORD53CCL5 PDCD1LG2 IFIT2 SNRPGCD55 PDP2 IGFL1 SQLECDH2 PHLDA1 IL1A STXBP1CHST9 PLAU IL1B SYT14CLDN1 PLAUR IL32 TFPI2CLDN4 PLK2 IL8 TGFACLMN PLK3 INSIG1 TGFB2COTL1 PRRG1 ITGA5 TGM2COX6C PSAT1 ITGBL1 THBS1CPA4 PSG5 JPH1 TIMP2CRYAB PTPN14 KLK7 TLCD1CTGF RAB11FIP1 KPNA7 TMEM154CTH RAB3B KRT18 TMEM171CTNNAL1 RBM14 TMEM27CYR61 RBMS2 KRT8 TNFCYTH3 RGNEF KRT81 TNFAIP3DENND3 RIMKLB LAMB1 TNFRSF9DHCR7 RND3 LDLR TNFSF18EBP SAA1 LIF TSC22D2ENC1 SAA2 LIPH TUFT1EPB41L2 SC4MOL LMBRD2 UBDERRFI1 SCD LOC100130876 UCA1EXPH5 SCD5 LOC642947 UCP2F3 SCML1 LOXL4 UGCGFASN SEMA7A LPHN2 UPK1BFDFT1 SERPINB10 LPIN1 UPP1FDPS SERPINB2 MACC1 VGLL1FGFBP1 SHROOM3 MFAP5 WIPI1FLNA SLC16A13 MICB

Hippo Signature b

Supplementary Figure 5 Generation of a Hippo Gene Expression Signature and localization of Yap in human LKB1-mutant tissues. (a) Microarray analysis on three different cancer cell lines reveal a core set of genes whose expression changes following siRNA knockdown of NF2 + LATS1/2, and for which this response is dependent on YAP/TAZ. Differentially

expressed genes were defined as those with at least 2 fold change in NF2/LATS2 double knockdown cells and a p value smaller than 0.05. (b) YAP immunohistochemistry on human SMAD4 juvenille polyposis (JP) intestinal polyp compared to a human LKB1 mutant Peutz-Jeghers (PJ) intestinal polyp. Scale bar, 500 mm.

© 2014 Macmillan Publishers Limited. All rights reserved.

Page 6: SUPPLEMENTARY INFORMATION INFORMATION  5 FIGURE S5 a SMAD4 JP Polyp Lkb1 PJ Polyp Yap1 ABL2 MID1 FST SLC16A6 ACAT2 MIR622 GADD45A SLC2A3 ACLY MYBL1 GADD45B

S U P P L E M E N TA RY I N F O R M AT I O N

6 WWW.NATURE.COM/NATURECELLBIOLOGY

FIGURE S6

01234567

- dox - dox+ dox + dox

Tum

or W

eigh

t (g)

5

15

25

35

45

55

>100 >200pixels diameter

- dox W4+ dox W4

+ dox W4 TET-oYap- dox W4 TET-o-Yap

W4tetOYapW4- dox + dox - dox + dox

W4tetOYap W4

a

b

0

1

2

3

4

5

6

7

LATS2 CTGF CYR61 AMOTL2

W4 shLATS2 cell line (+dox)W4-ParentalshLATS-Clone 1shLATS-Clone 2shLATS-Clone 3shLATS-Clone 4

00.20.40.60.8

11.2

siCTR

siScri

b-A

siScri

b-B

siScri

b-C

-DOX+DOX

SCRIB

Rel

ativ

e Ex

pres

sion

Rel

ativ

e Ex

pres

sion

c d

Supplementary Figure 6 Yap1 acts downstream of LKB1 and can overcome LKB1 tumor suppressive function. (a) Quantification of triplicate samples of number and size of W4, W4TetOYAP, +/- doxycycline colonies in soft agar assays. n= 3 biological triplicates (b) Tumor weights of W4, W4TetOYAP, +/- doxycycline after seven weeks. Representative images of nude mice carrying

xenografts with W4, W4TetOYAP tumors. N = 7 mice per each of the four genotypes. (c) qPCR validation of shRNA knockdown of LATS2 and activation of YAP-target genes in W4 cells. N = 3 biological replicates. (d) qPCR of Scribble following Scribble siRNA knockdown in the presence of LKB1 activation. n= 3 biological replicates. Error bars represent mean ± SD.

© 2014 Macmillan Publishers Limited. All rights reserved.

Page 7: SUPPLEMENTARY INFORMATION INFORMATION  5 FIGURE S5 a SMAD4 JP Polyp Lkb1 PJ Polyp Yap1 ABL2 MID1 FST SLC16A6 ACAT2 MIR622 GADD45A SLC2A3 ACLY MYBL1 GADD45B

S U P P L E M E N TA RY I N F O R M AT I O N

WWW.NATURE.COM/NATURECELLBIOLOGY 7

FIGURE S7

23.66

9.668

2.5

0

5

10

15

20

25

30

35

>100 >200

diameter (pixels)

- dox+ dox

# of

Col

onie

s

b

0.0

5000.0

10000.0

15000.0

20000.0

25000.0

30000.0

Tum

or S

ize

(pix

els2

)

-dox

+do

x

0.00.51.01.52.02.53.03.54.04.55.0

-dox

+do

x

Aver

age

Tum

or #

c

d

0

0.2

0.4

0.6

0.8

1

1.2DV90DV90-shA + DOXDV90-shB + DOXHC1833HC1833-shA + DOXHC1833-shB + DOX

Rel

ativ

e Ex

pres

sion

YAP

DV9

0-sh

YapA

HC

1833

-shY

apA

-dox +dox

0

0.2

0.4

0.6

0.8

1

1.2

LKB1Yap

+/+

Lkb1fl

/fl

Lkb1/Y

apfl/f

l

Rel

ativ

e m

RN

A Ex

pres

sion

f

a

g

0.0000

0.0500

0.1000

0.1500

0.2000

0.2500

1 2 3 4 5 6 7

DV90-shA -DOXDV90-shA +DOXHC1833-shA -DOXHC1833-shA +DOX

Abso

rban

ce (4

90nm

)Pr

olife

ratio

n

Days

e

Supplementary Figure 7 Loss of Yap1 in LKB1 mutant xenograft show tumor growth inhibition. (a) Quantification of triplicate samples of number and size of W4, W4TetOYAP, +/- doxycycline colonies. n=3 biological replicates (b-c) Average tumor size and number per mouse following intravenous injection of 1x106 A549iYAPshRNA cells (-/+ doxycycline) for 6 weeks. n=3 mice per group (d-f) Two cell lines that are low in YAP

target gene expression were infected with shYAP1 hairpins and assessed for proliferation using MTS assays (e) and soft agar colony formation assay (f) n = 3 biological replicates. Scale bar, 500 mm. (g) Expression levels of LKB1 and YAP following Ad-cre administration in Lkb1-floxed and Lkb1/YAP floxed livers. n= 4 mice per genotype. Error bars represent mean ± SD.

© 2014 Macmillan Publishers Limited. All rights reserved.

Page 8: SUPPLEMENTARY INFORMATION INFORMATION  5 FIGURE S5 a SMAD4 JP Polyp Lkb1 PJ Polyp Yap1 ABL2 MID1 FST SLC16A6 ACAT2 MIR622 GADD45A SLC2A3 ACLY MYBL1 GADD45B

S U P P L E M E N TA RY I N F O R M AT I O N

8 WWW.NATURE.COM/NATURECELLBIOLOGY

Supplementary Figure 8 Full scans

© 2014 Macmillan Publishers Limited. All rights reserved.